Intra-Cellular Therapies Inc
NASDAQ:ITCI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Intra-Cellular Therapies Inc
NASDAQ:ITCI
|
US |
|
Canaccord Genuity Group Inc
TSX:CF
|
CA |
|
Lynas Rare Earths Ltd
ASX:LYC
|
MY |
|
Firefinch Ltd
ASX:FFX
|
AU |
|
Reservoir Media Inc
NASDAQ:RSVR
|
US |
|
D
|
Daeryuk Can Co Ltd
KOSDAQ:004780
|
KR |
|
Dovalue SpA
MIL:DOV
|
IT |
|
Plus500 Ltd
LSE:PLUS
|
IL |
|
N
|
Novo Nordisk A/S
XBER:NOVA
|
DK |
|
S
|
S & P Syndicate PCL
SET:SNP
|
TH |
|
GPO Plus Inc
OTC:GPOX
|
US |
|
A
|
Ameresco Inc
F:4AM
|
US |
Intrinsic Value
The
intrinsic value for
Intra-Cellular Therapies Inc (ITCI)
under the Base Case is
hidden
USD.
Compared with the current market price of 131.87 USD, the stock appears
hidden
.
ITCI looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether ITCI usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Intra-Cellular Therapies Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Intra-Cellular Therapies Inc
Earnings Waterfall
Intra-Cellular Therapies Inc
The
intrinsic value for
Intra-Cellular Therapies Inc (ITCI)
under the Base Case is
hidden
USD.
Compared with the current market price of 131.87 USD, the stock appears hidden .